Angiosarcoma — Trials

Angiosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 51–53 of 53 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00887809	Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes	completed	Phase 2	47	Memorial Sloan Kettering Cancer CenterOTHER	1	Jan 25, 2016	clinicaltrials
NCT01623869	Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery	completed	Phase 2	16	National Cancer Institute (NCI)NIH	1	Oct 19, 2015	clinicaltrials